See α-Synuclein. Candidate tracer SY08 detects α-synuclein deposits in the brainstem (right) and parietal cortex (left) of ...

A new consortium aims to speed the pace of basic science discovery in AD and related diseases. A future AI assistant is to ...

Vaccine Step Down. A person’s probability of developing dementia over seven years increased with age. It was higher in the ...

Do you know a conference you think we should list? Let us know by sending us an email with the details to [email protected].

Like lecanemab before it, donanemab’s path to market has been slow and rocky. In the U.S., the antibody received Food and Drug Administration approval about nine months ago, but only a few hundred ...

First author Hamilton Oh, now at Icahn School of Medicine at Mt. Sinai, New York, and colleagues identified these potential markers during a proteomics analysis of CSF from 3,397 participants in six ...

I am consultant for Janssen pharmaceutica, Remynd NV, Eisai and other companies ...

Already have an account? Log in.

As the baby boom generation reaches its hopefully golden years, scientists have been projecting a doubling of dementia cases in the U.S. by 2050, alarming health care agencies, the public, and health ...